Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience.
| Author | |
|---|---|
| Abstract |
:
Cure rates for chronic hepatitis C have improved dramatically with direct-acting antivirals (DAAs), but treatment barriers remain. We aimed to compare treatment initiation rates and barriers across both interferon-based and DAA-based eras. |
| Year of Publication |
:
0
|
| Journal |
:
BMJ open gastroenterology
|
| Volume |
:
4
|
| Issue |
:
1
|
| Number of Pages |
:
e000181
|
| Date Published |
:
2017
|
| URL |
:
http://dx.doi.org/10.1136/bmjgast-2017-000181
|
| DOI |
:
10.1136/bmjgast-2017-000181
|
| Short Title |
:
BMJ Open Gastroenterol
|
| Download citation |
